Insufficient scRNA-seq data for expression of EFNA4 at single-cell level.
Insufficient scRNA-seq data for expression of EFNA4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 527.12 | 179 / 180 | 100% | 46.92 | 430 / 430 |
uterus | 99% | 358.60 | 169 / 170 | 99% | 53.27 | 455 / 459 |
prostate | 100% | 522.29 | 244 / 245 | 99% | 39.24 | 496 / 502 |
thymus | 100% | 374.69 | 652 / 653 | 97% | 26.95 | 587 / 605 |
lung | 98% | 255.23 | 568 / 578 | 98% | 41.28 | 1135 / 1155 |
bladder | 95% | 253.10 | 20 / 21 | 99% | 50.90 | 498 / 504 |
stomach | 95% | 237.89 | 342 / 359 | 98% | 47.02 | 281 / 286 |
breast | 95% | 447.80 | 437 / 459 | 97% | 61.93 | 1087 / 1118 |
intestine | 93% | 426.82 | 903 / 966 | 99% | 54.93 | 521 / 527 |
esophagus | 90% | 405.39 | 1295 / 1445 | 97% | 29.78 | 178 / 183 |
skin | 99% | 1107.65 | 1786 / 1809 | 88% | 18.51 | 415 / 472 |
pancreas | 89% | 165.14 | 293 / 328 | 94% | 37.34 | 167 / 178 |
liver | 97% | 231.94 | 219 / 226 | 81% | 22.00 | 329 / 406 |
kidney | 100% | 269.62 | 89 / 89 | 66% | 10.35 | 594 / 901 |
adrenal gland | 100% | 621.04 | 258 / 258 | 33% | 15.50 | 75 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.81 | 29 / 29 |
spleen | 100% | 349.06 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 33.63 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 31.43 | 1 / 1 |
adipose | 89% | 188.35 | 1073 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 211.31 | 763 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 74% | 124.19 | 988 / 1335 | 0% | 0 | 0 / 0 |
heart | 68% | 103.81 | 584 / 861 | 0% | 0 | 0 / 0 |
brain | 28% | 34.69 | 731 / 2642 | 25% | 3.65 | 178 / 705 |
eye | 0% | 0 | 0 / 0 | 31% | 3.65 | 25 / 80 |
muscle | 7% | 8.26 | 56 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0007267 | Biological process | cell-cell signaling |
GO_0007411 | Biological process | axon guidance |
GO_0098552 | Cellular component | side of membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005005 | Molecular function | transmembrane-ephrin receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0046875 | Molecular function | ephrin receptor binding |
Gene name | EFNA4 |
Protein name | Ephrin-A4 (EPH-related receptor tyrosine kinase ligand 4) (LERK-4) |
Synonyms | EPLG4 LERK4 |
Description | FUNCTION: Cell surface GPI-bound ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Binds promiscuously Eph receptors residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. May play a role in the interaction between activated B-lymphocytes and dendritic cells in tonsils. |
Accessions | ENST00000359751.8 [P52798-2] ENST00000368409.8 [P52798-1] P52798 ENST00000427683.2 [P52798-3] |